26 Mar 2026 CMB International Global Markets | Equity Research | Company Update WuXi Biologics (2269 HK) WuXi Biologics (2269 HK) - | Target Price | HK$39.00 | | --- | --- | | (Previous TP | HK$35.60) | | Up/Downside | 17.7% | | Current Price | HK$33.14 | China Healthcare Resilient demand amid macro uncertainties WuXi Bio reported financial results for 2025, with revenue increasing by 16.7% YoY and adj. attributable net profit rising by 17.9% YoY. Revenue and adj. net profit exceeded our estimates by 1.2% a ...